MYC and cholangiocarcinoma: For example, epithelial-mesenchymal transition genes and MYC targets are enriched among stabilized mRNAs across several cancer types, while metabolic pathways such as oxidative phosphorylation and lipid metabolism are highly enriched among destabilized mRNAs, most noticeably in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC) and head-neck squamous cell carcinoma (HNSC).